Art

J-GLOBAL ID：201302254007978177   Reference number：13A0962772

Chaperone therapy update: Fabry disease, G_M1-gangliosidosis and Gaucher disease

シャペロン療法アップデート Fabry病とG_M1-ガングリオシド蓄積症とGaucher病

Author (1)： SUZUKI Yoshiyuki (International Univ. of Health and Welfare Graduate School, Otawara, JPN)
Material： Brain & Development  (Brain & Dev)
Volume： 35  Issue： 6  Page： 515-523  Publication year： Jun. 2013 
JST Material Number： W0814A  ISSN： 0387-7604  Document type： Article
Article type： 文献レビュー  Country of issue： Netherlands (NLD)  Language： ENGLISH (EN)

Thesaurus term： *chaperone protein ,...
Semi thesaurus term： *シャペロン療法 ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=13A0962772&from=J-GLOBAL&jstjournalNo=W0814A") }}

JST classification (1)： Treatment for congenital diseases,deformities.  (GD03030R)

Reference (65)：

• Online Mendelian Inheritance in Man (OMIM). An Online Catalog of Human Genes and Genetic Disorders. Baltimore: McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University. http://www.omim.org/
• De Duve C, Wattiaux R. Functions of lysosomes. Annu Rev Physiol 1966;28:435-92.
• Suzuki Y, Ogawa S, Sakakibara Y. Chaperone therapy for neuronopathic lysosomal diseases: competitive inhibitors as chemical chaperones for enhancement of mutant enzyme activities. Perspect Med Chem 2009;3:7-19.
• Brady RO. Emerging strategies for the treatment of hereditary metabolic storage disorders. Rejuvenation Res 2006;9:237-44.
• Suzuki Y, Sakuraba H, Hayashi K, Suzuki K, Imahori K. β-Galactosidase-neuraminidase deficiency: restoration of β-galactosidase activity by protease inhibitors. J Biochem 1981;90:271-3.

Terms in the title (6)： シャペロン ,  療法 ,  アップデート ,  Fabry病 ,  ガングリオシド蓄積症 ,  Gaucher病